StonvexLoading…
StonvexStonvexStonvexCore line items from SCHW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-16 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $6.86B | $6.48B | $23.92B | $17.59B | $11.45B |
Operating Income | Not available | $3.19B | $11.46B | $8.28B | $5.26B |
Net Income | Not available | $2.48B | $8.85B | $6.39B | $4.04B |
EPS (Diluted) | $1.54 | $1.37 | $4.65 | $3.33 | $2.07 |
Total Assets | Not available | $493.32B | $491.00B | $465.25B | $458.94B |
Total Liabilities | Not available | $444.08B | $441.57B | $415.87B | $409.49B |
Cash & Equivalents | Not available | $44.98B | $46.03B | $30.57B | $32.20B |
Free Cash Flow OCF − CapEx | Not available | $7.20B | $8.76B | $9.68B | $9.29B |
Shares Outstanding | Not available | 1.75B | 1.81B | 1.82B | 1.82B |